Introduction to Adimmune

Adimmune is the first professional vaccine R&D and production company founded in 1965 in Taiwan. 

It has the ability to manufacture vaccines and biological preparations from R&D to production. 

It is also the only influenza vaccine factory in Taiwan certified by the United States and the European Union. 

Adimmune is committed to becoming the world's leading supplier of biologics, improving operational performance year by year through market internationalization, diversified technology platforms and continuous production capacity expansion. 

國光生物科技成立於1965年，是台灣第一家專業疫苗研發和生產公司。

具備從研發到生產疫苗及生物製劑的製造能力。

也是台灣唯一獲得美國及歐盟認證的流感疫苗工廠。 

Adimmune致力於成為全球領先的生物製劑供應商，透過市場國際化、多元化技術平台和持續產能擴張，經營績效逐年提升。

Recently, Adimmune had signed a strategic cooperation alliance with Becton Dickinson, a leading global syringe manufacturer. 

We aimed to enter the international OEM market and create a transnational biologics supply chain. 

Also, Adimmune had remained a long term technical cooperation with the Daiichi Sankyo vaccine company in Japan for over 50 years. 

Focusing on the production of tetanus vaccine, Japanese encephalitis vaccine, influenza vaccine and avian influenza vaccine. 

I believe cooperation with other experts among various fields would greatly increase our competitiveness.

近日，Adimmune與全球領先針筒製造商Becton Dickinson簽署策略合作聯盟。

我們的目標是進軍國際OEM市場，打造跨國生物藥供應鏈。

並且，Adimmune與日本第一三共疫苗公司維持了50多年的長期技術合作。

著重在生產破傷風疫苗、B型腦炎疫苗、流感疫苗和禽流感疫苗。

我相信與各領域的其他專家的合作將大大提高我們的競爭力。